Cargando…

Unilateral Uterine Artery Embolization as a Treatment for Patients with Symptomatic Fibroids—Experience in a Case Series

Background and Objectives: Uterine artery embolization (UAE) has become an accepted and widely performed therapy for patients with symptomatic (reporting at least two of the following symptoms: severe or prolonged menstrual bleeding, abdominal pain, tension in abdomen, problems with urination, const...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyra, Krzysztof, Szmygin, Maciej, Szmygin, Hanna, Woźniak, Sławomir, Jargiełło, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783256/
https://www.ncbi.nlm.nih.gov/pubmed/36556934
http://dx.doi.org/10.3390/medicina58121732
_version_ 1784857535089475584
author Pyra, Krzysztof
Szmygin, Maciej
Szmygin, Hanna
Woźniak, Sławomir
Jargiełło, Tomasz
author_facet Pyra, Krzysztof
Szmygin, Maciej
Szmygin, Hanna
Woźniak, Sławomir
Jargiełło, Tomasz
author_sort Pyra, Krzysztof
collection PubMed
description Background and Objectives: Uterine artery embolization (UAE) has become an accepted and widely performed therapy for patients with symptomatic (reporting at least two of the following symptoms: severe or prolonged menstrual bleeding, abdominal pain, tension in abdomen, problems with urination, constipation or anemia) uterine fibroids. Although in the majority of cases, bilateral occlusion is required to obtain a successful clinical outcome, there are patients in whom treatment of only one uterine artery could be attempted. There are several reasons for unilateral UAE: hemodynamic conditions, technical difficulties, anatomical variants and unilateral dominancy of blood supply to the fibroid. Our aim is to present our 10-year experience with unilateral UAE and evaluate the radiological and clinical outcomes. Materials and Methods: Records of 369 patients with fibroids who underwent UAE from 2010 to 2021 were analyzed. We identified 26 patients treated with unilateral uterine artery embolization and analyzed the data of these patients. All patients attended medical consultation, were assessed using a five-grade symptom scale and underwent MRI examination. Clinical response was evaluated at least 6 months after the procedure and was categorized to one of the following groups: complete improvement, partial improvement, no change and a worsening in symptoms. Results: Twenty-two patients (85%) reported at least partial improvement 6 months following the procedure. One patient required secondary embolization due to recanalization. The secondary procedure was successful, and complete improvement was achieved. One patient did not observe any clinical improvement, and in two cases, symptom recurrence was observed. All three patients were referred for surgical treatment. No major complications were noted. Overall, the success rate was 88%. Conclusions: The results of our study support the statement that elective unilateral embolization is an appropriate treatment in patients with a dominant uterine artery.
format Online
Article
Text
id pubmed-9783256
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97832562022-12-24 Unilateral Uterine Artery Embolization as a Treatment for Patients with Symptomatic Fibroids—Experience in a Case Series Pyra, Krzysztof Szmygin, Maciej Szmygin, Hanna Woźniak, Sławomir Jargiełło, Tomasz Medicina (Kaunas) Article Background and Objectives: Uterine artery embolization (UAE) has become an accepted and widely performed therapy for patients with symptomatic (reporting at least two of the following symptoms: severe or prolonged menstrual bleeding, abdominal pain, tension in abdomen, problems with urination, constipation or anemia) uterine fibroids. Although in the majority of cases, bilateral occlusion is required to obtain a successful clinical outcome, there are patients in whom treatment of only one uterine artery could be attempted. There are several reasons for unilateral UAE: hemodynamic conditions, technical difficulties, anatomical variants and unilateral dominancy of blood supply to the fibroid. Our aim is to present our 10-year experience with unilateral UAE and evaluate the radiological and clinical outcomes. Materials and Methods: Records of 369 patients with fibroids who underwent UAE from 2010 to 2021 were analyzed. We identified 26 patients treated with unilateral uterine artery embolization and analyzed the data of these patients. All patients attended medical consultation, were assessed using a five-grade symptom scale and underwent MRI examination. Clinical response was evaluated at least 6 months after the procedure and was categorized to one of the following groups: complete improvement, partial improvement, no change and a worsening in symptoms. Results: Twenty-two patients (85%) reported at least partial improvement 6 months following the procedure. One patient required secondary embolization due to recanalization. The secondary procedure was successful, and complete improvement was achieved. One patient did not observe any clinical improvement, and in two cases, symptom recurrence was observed. All three patients were referred for surgical treatment. No major complications were noted. Overall, the success rate was 88%. Conclusions: The results of our study support the statement that elective unilateral embolization is an appropriate treatment in patients with a dominant uterine artery. MDPI 2022-11-27 /pmc/articles/PMC9783256/ /pubmed/36556934 http://dx.doi.org/10.3390/medicina58121732 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pyra, Krzysztof
Szmygin, Maciej
Szmygin, Hanna
Woźniak, Sławomir
Jargiełło, Tomasz
Unilateral Uterine Artery Embolization as a Treatment for Patients with Symptomatic Fibroids—Experience in a Case Series
title Unilateral Uterine Artery Embolization as a Treatment for Patients with Symptomatic Fibroids—Experience in a Case Series
title_full Unilateral Uterine Artery Embolization as a Treatment for Patients with Symptomatic Fibroids—Experience in a Case Series
title_fullStr Unilateral Uterine Artery Embolization as a Treatment for Patients with Symptomatic Fibroids—Experience in a Case Series
title_full_unstemmed Unilateral Uterine Artery Embolization as a Treatment for Patients with Symptomatic Fibroids—Experience in a Case Series
title_short Unilateral Uterine Artery Embolization as a Treatment for Patients with Symptomatic Fibroids—Experience in a Case Series
title_sort unilateral uterine artery embolization as a treatment for patients with symptomatic fibroids—experience in a case series
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783256/
https://www.ncbi.nlm.nih.gov/pubmed/36556934
http://dx.doi.org/10.3390/medicina58121732
work_keys_str_mv AT pyrakrzysztof unilateraluterinearteryembolizationasatreatmentforpatientswithsymptomaticfibroidsexperienceinacaseseries
AT szmyginmaciej unilateraluterinearteryembolizationasatreatmentforpatientswithsymptomaticfibroidsexperienceinacaseseries
AT szmyginhanna unilateraluterinearteryembolizationasatreatmentforpatientswithsymptomaticfibroidsexperienceinacaseseries
AT wozniaksławomir unilateraluterinearteryembolizationasatreatmentforpatientswithsymptomaticfibroidsexperienceinacaseseries
AT jargiełłotomasz unilateraluterinearteryembolizationasatreatmentforpatientswithsymptomaticfibroidsexperienceinacaseseries